Immune history shapes human antibody responses to H5N1 influenza viruses.

Autor: Garretson TA, Liu J, Li SH, Scher G, Santos JJS, Hogan G, Vieira MC, Furey C, Atkinson RK, Ye N, Ort J, Kim K, Hernandez KA, Eilola T, Schultz DC, Cherry S, Cobey S, Hensley SE

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Nov 02. Date of Electronic Publication: 2024 Nov 02.

COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study.

Autor: Anderson AR; PRISMA Health Comprehensive Sickle Cell Disease Program, Division of Pediatric Hematology-Oncology, University of South Carolina School of Medicine, Greenville, SC., Strouse JJ; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC., Manwani D; Children's Hospital at Montefiore, Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY., Brandow AM; Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin and Children's Research Institute of Children's Wisconsin, Milwaukee, WI., Vichinsky E; Benioff Children's Hospital Oakland, Department of Pediatrics, UCSF, Oakland, CA., Campbell A; Department of Pediatrics, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC., Leavey PJ; Simmons Comprehensive Cancer Center, Children's Medical Center, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Nero A; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX., Ibrahim IF; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX., Field JJ; Department of Medicine, Medical College of Wisconsin, Versiti Blood Research Institute, Milwaukee, WI., Baer A; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Soto-Calderon H; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Vincent L; Department of Medicine, University of Pennsylvania, Philadelphia, PA., Zhao Y; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Santos JJS; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Hensley SE; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Mortier N; ASH Research Collaborative, Washington, DC., Lanzkron S; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD., Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, PA.

Publikováno v: Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4549-4553.

Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.

Autor: Hu Z; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., López-Muñoz AD; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Kosik I; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Li T; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Callahan V; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Brooks K; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Yee DS; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Holly J; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Santos JJS; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Castro Brant A; Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, National Cancer Institute, NIH, Frederick, MD 21702., Johnson RF; SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Takeda K; Microscopy and Imaging Core Facility, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993., Zheng ZM; Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, National Cancer Institute, NIH, Frederick, MD 21702., Brenchley JM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Yewdell JW; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Fox JM; Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jul 16; Vol. 121 (29), pp. e2310421121. Date of Electronic Publication: 2024 Jul 08.

Second-order scattering sensor based on the Zn 0.97 La 0.03 O compound for selective and stable detection of glycated albumin.

Autor: Dos Santos JJS; Garanhuns Campus, University of Pernambuco (UPE), Garanhuns 55294-902, PE, Brazil., Garcia RRP; Graduate Program in Materials Science and Engineering, Federal University of Piauí (UFPI), Teresina 64049-550, PI, Brazil; Engineering Campus - Academic Unit of Cabo de Santo Agostinho, Federal Rural University of Pernambuco (UFRPE), Cabo de Santo Agostinho 54518-430, PE, Brazil., Soares AS; Graduate Program in Materials Science and Engineering, Federal University of Piauí (UFPI), Teresina 64049-550, PI, Brazil., de Amorim Silva EG; Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil., Neves JL; Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil., Menezes TM; Engineering Campus - Academic Unit of Cabo de Santo Agostinho, Federal Rural University of Pernambuco (UFRPE), Cabo de Santo Agostinho 54518-430, PE, Brazil. Electronic address: thais.meira@ufrpe.br.

Publikováno v: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Jun 05; Vol. 314, pp. 124176. Date of Electronic Publication: 2024 Mar 19.

Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.

Autor: Painter MM; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Johnston TS; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA, USA., Lundgreen KA; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Santos JJS; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Qin JS; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Goel RR; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Apostolidis SA; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Division of Rheumatology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Mathew D; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Fulmer B; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Williams JC; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., McKeague ML; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Pattekar A; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Goode A; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Nasta S; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Baxter AE; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Giles JR; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Skelly AN; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Felley LE; Division of Infectious Disease, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., McLaughlin M; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Weaver J; Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Kuthuru O; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Dougherty J; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Adamski S; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Long S; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Kee M; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Clendenin C; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., da Silva Antunes R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA., Huang AC; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Rader DJ; Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Penn Medicine Biobank, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Hensley SE; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Bates P; Department of Microbiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Greenplate AR; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Wherry EJ; Institute for Immunology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.; Immune Health, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. wherry@pennmedicine.upenn.edu.

Publikováno v: Nature immunology [Nat Immunol] 2023 Oct; Vol. 24 (10), pp. 1711-1724. Date of Electronic Publication: 2023 Sep 21.